Ralph Grosswald - 05 Mar 2026 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Role
SVP OF OPERATIONS
Signature
/s/ Greg Duncan, Attorney-in-Fact
Issuer symbol
DWTX
Transactions as of
05 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 16:20:01 UTC
Previous filing
05 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grosswald Ralph SVP OF OPERATIONS C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA /s/ Greg Duncan, Attorney-in-Fact 06 Mar 2026 0001826084

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DWTX Stock Option (right to buy) Award +82,500 $0.000000* 82,500 05 Mar 2026 Common Stock 82,500 $2.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on March 5, 2027 and 1/24th monthly thereafter.